Hospice News

SEPTEMBER 19, 2022

While hospice and home health M&A continue to burgeon, non-medical home care is starting to slip out from under their shadows. Deal volume for non-medical home care companies outstripped that for hospice or home health during the first half of the year. Hospice market to stay mighty.

Home care 253

Home care Hospice Homecare 2021 253

Hospice News

NOVEMBER 1, 2022

Addus HomeCare Corporation’s (NASDAQ: ADUS) is shifting its M&A strategy away from hospice deals to focus on its home health and personal care businesses. Texas-based Addus provides personal, home health and hospice care across 207 locations in 22 states, reaching roughly 46,500 patients annually.

Personal care 208

Personal care Hospice Homecare Medicare 208

Hospice News

AUGUST 29, 2022

Disruption in home health reimbursement has an influence on the hospice mergers and acquisitions market, particularly among the rising number of companies offering both services. So many industry consolidators paused all but the most strategic deals and pivoted to hospice. “.

2026 205

2026 Hospice 2025 2020 205

Hospice News

MAY 10, 2023

As Addus HomeCare Corporation (NASDAQ: ADUS) sinks teeth into acquisitions, the company will be taking smaller bites when it comes to hospice deals. Addus has indicated for roughly the last year that it will orient its M&A strategy towards its home health and personal care services, with hospice becoming less of a priority.

Personal care 207

Personal care Homecare 2022 In-home health 207

Hospice News

DECEMBER 12, 2022

Though hospice deal volume dipped in 2022 compared to previous years, five particular transactions could paint a larger picture of where investors see value in the space. These interesting, unusual or groundbreaking deals could signal what’s to come in 2023 and help shape the hospice market’s long-term future. s (NYSE: HUM) $2.8

2022 222

2022 Hospice 2023 2021 222